HQY RSI Chart
Last 7 days
-2.2%
Last 30 days
-2.0%
Last 90 days
21%
Trailing 12 Months
32.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 999.6M | 0 | 0 | 0 |
2023 | 861.7M | 900.5M | 937.9M | 971.0M |
2022 | 756.6M | 778.0M | 795.1M | 831.2M |
2021 | 733.6M | 727.8M | 740.8M | 741.4M |
2020 | 532.0M | 635.0M | 724.4M | 746.6M |
2019 | 287.2M | 304.4M | 319.9M | 406.6M |
2018 | 229.5M | 244.0M | 258.2M | 271.9M |
2017 | 178.4M | 189.8M | 202.5M | 215.9M |
2016 | 126.8M | 140.9M | 154.6M | 167.4M |
2015 | 87.9M | 97.5M | 107.1M | 115.8M |
2014 | 62.0M | 67.6M | 73.5M | 80.1M |
2013 | 46.1M | 50.1M | 54.1M | 58.0M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 22, 2024 | kessler jon | sold | -2,694,730 | 79.8084 | -33,765 | president and ceo |
Mar 22, 2024 | kessler jon | acquired | 840,000 | 14.00 | 60,000 | president and ceo |
Mar 01, 2024 | ladd delano | sold | -211,265 | 82.59 | -2,558 | evp, gc & corporate secretary |
Feb 09, 2024 | ladd delano | sold | -199,920 | 80.00 | -2,499 | evp, gc & corporate secretary |
Feb 01, 2024 | natarajan rajesh | acquired | - | - | 1,124 | - |
Feb 01, 2024 | parker stuart b. | acquired | - | - | 1,058 | - |
Feb 01, 2024 | dillon adrian t | acquired | - | - | 1,455 | - |
Jan 08, 2024 | ladd delano | sold | -181,020 | 70.00 | -2,586 | evp, gc & corporate secretary |
Jan 05, 2024 | ladd delano | sold (taxes) | -12,715 | 67.6367 | -188 | evp, gc & corporate secretary |
Jan 05, 2024 | rosner elimelech | sold (taxes) | -82,179 | 67.6371 | -1,215 | evp, chief technology officer |
Which funds bought or sold HQY recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 26, 2024 | Fairman Group, LLC | new | - | 1,989 | 1,989 | -% |
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -3.6 | -84,240 | 589,209 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 1.22 | -50,578,300 | 571,473,000 | 0.01% |
Mar 04, 2024 | TUCKER ASSET MANAGEMENT LLC | reduced | -75.00 | -451 | 133 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 149 | 83,591,100 | 149,789,000 | 0.01% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -3.04 | -1,416,670 | 10,393,300 | 0.04% |
Feb 26, 2024 | Neo Ivy Capital Management | sold off | -100 | -263,000 | - | -% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -2.66 | -449,000 | 3,400,000 | 0.03% |
Feb 21, 2024 | Raleigh Capital Management Inc. | added | 26.12 | 1,416 | 11,205 | -% |
Feb 16, 2024 | Spouting Rock Asset Management, LLC | reduced | -5.06 | -113,440 | 706,692 | 0.26% |
Unveiling HealthEquity Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Peers (Alternatives to HealthEquity Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 454.6B | 371.6B | 20.31 | 1.22 | ||||
CI | 106.2B | 195.3B | 19.78 | 0.54 | ||||
CVS | 100.0B | 357.8B | 11.97 | 0.28 | ||||
HCA | 87.7B | 65.0B | 16.74 | 1.35 | ||||
CNC | 41.9B | 154.0B | 15.51 | 0.27 | ||||
UHS | 12.6B | 14.3B | 17.56 | 0.88 | ||||
DVA | 12.0B | 12.1B | 17.36 | 0.99 | ||||
MID-CAP | ||||||||
CHE | 9.7B | 2.3B | 35.74 | 4.3 | ||||
ACHC | 7.2B | 2.9B | -333.68 | 2.47 | ||||
AMN | 2.3B | 3.8B | 11.05 | 0.61 | ||||
AMEH | 2.3B | 1.4B | 37.6 | 1.65 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.93 | 1.59 | ||||
BKD | 1.2B | 3.0B | -6.6 | 0.41 | ||||
BEAT | 56.3M | - | -3.85 | - | ||||
AMS | 16.9M | 20.7M | 83.48 | 0.82 |
HealthEquity Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 5.3% | 262 | 249 | 244 | 244 | 234 | 216 | 206 | 206 | 203 | 180 | 189 | 184 | 188 | 179 | 176 | 190 | 201 | 157 | 87.00 | 87.00 | 76.00 |
Gross Profit | 3.1% | 163 | 158 | 151 | 148 | 135 | 127 | 118 | 111 | 106 | 103 | 112 | 103 | 101 | 105 | 102 | 108 | 114 | 96.00 | 58.00 | 58.00 | 44.00 |
Operating Expenses | -2.4% | 124 | 128 | 126 | 125 | 122 | 121 | 120 | 118 | 133 | 104 | 113 | 99.00 | 103 | 93.00 | 93.00 | 93.00 | 99.00 | 86.00 | 34.00 | 30.00 | 28.00 |
S&GA Expenses | 4.6% | 21.00 | 20.00 | 19.00 | 20.00 | 19.00 | 17.00 | 16.00 | 17.00 | 16.00 | 13.00 | 15.00 | 14.00 | 13.00 | 13.00 | 12.00 | 11.00 | 14.00 | 13.00 | 8.00 | 9.00 | 8.00 |
R&D Expenses | -0.7% | 55.00 | 56.00 | 55.00 | 53.00 | 53.00 | 49.00 | 47.00 | 45.00 | 46.00 | 38.00 | 38.00 | 35.00 | 32.00 | 31.00 | 31.00 | 31.00 | 32.00 | 24.00 | 12.00 | 11.00 | 10.00 |
EBITDA Margin | 8.1% | 0.25* | 0.23* | 0.21* | 0.18* | 0.16* | 0.09* | 0.09* | 0.10* | 0.10* | 0.14* | 0.15* | 0.17* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 0.7% | 14.00 | 14.00 | 13.00 | 15.00 | 14.00 | 12.00 | 11.00 | 10.00 | 11.00 | 12.00 | 7.00 | 7.00 | 7.00 | 7.00 | 9.00 | 12.00 | 14.00 | 10.00 | 0.00 | 0.00 | -0.08 |
Income Taxes | -47.7% | 3.00 | 6.00 | 4.00 | 6.00 | 0.00 | -4.54 | -3.22 | -4.41 | -10.95 | -4.09 | -3.97 | -3.45 | -6.71 | 2.00 | -0.54 | 0.00 | -0.42 | -9.92 | 4.00 | 9.00 | 3.00 |
Earnings Before Taxes | 40.9% | 30.00 | 21.00 | 14.00 | 10.00 | 0.00 | -6.18 | -13.87 | -18.05 | -43.76 | -9.12 | -7.78 | -6.07 | -1.34 | 4.00 | -0.69 | 2.00 | -0.61 | -31.25 | 24.00 | 51.00 | 16.00 |
EBT Margin | 60.8% | 0.08* | 0.05* | 0.02* | -0.01* | -0.04* | -0.10* | -0.11* | -0.10* | -0.09* | -0.03* | -0.01* | -0.01* | - | - | - | - | - | - | - | - | - |
Net Income | 79.7% | 26.00 | 15.00 | 11.00 | 4.00 | -0.21 | -1.64 | -10.65 | -13.64 | -32.82 | -5.04 | -3.82 | -2.61 | 5.00 | 2.00 | -0.15 | 2.00 | -0.19 | -21.33 | 19.00 | 42.00 | 13.00 |
Net Income Margin | 85.7% | 0.06* | 0.03* | 0.01* | -0.01* | -0.03* | -0.07* | -0.08* | -0.07* | -0.06* | -0.01* | 0.00* | 0.01* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 35.3% | 77.00 | 57.00 | 77.00 | 31.00 | 55.00 | 47.00 | 39.00 | 6.00 | 49.00 | 21.00 | 33.00 | 28.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 2.3% | 3,164 | 3,094 | 3,066 | 3,035 | 3,089 | 3,065 | 3,074 | 3,065 | 3,107 | 3,100 | 3,149 | 3,162 | 2,710 | 2,657 | 2,664 | 2,562 | 2,565 | 2,560 | 1,098 | 597 | 510 |
Current Assets | 17.5% | 557 | 474 | 423 | 358 | 383 | 332 | 309 | 279 | 351 | 764 | 861 | 865 | 460 | 396 | 383 | 284 | 297 | 270 | 854 | 365 | 395 |
Cash Equivalents | 20.9% | 404 | 334 | 290 | 226 | 254 | 210 | 177 | 161 | 225 | 649 | 754 | 737 | 329 | 299 | 269 | 171 | 192 | 175 | 815 | 329 | 361 |
Net PPE | -21.5% | 6.00 | 8.00 | 9.00 | 11.00 | 13.00 | 16.00 | 18.00 | 21.00 | 23.00 | 25.00 | 27.00 | 27.00 | 29.00 | 32.00 | 35.00 | 36.00 | 33.00 | 35.00 | 10.00 | 8.00 | 8.00 |
Goodwill | 0% | 1,648 | 1,648 | 1,648 | 1,648 | 1,648 | 1,646 | 1,646 | 36.00 | 1,646 | 282 | 1,364 | 1,364 | 1,327 | 1,327 | 1,334 | 1,333 | 1,333 | 1,323 | 5.00 | 5.00 | 5.00 |
Liabilities | 2.1% | 1,129 | 1,106 | 1,117 | 1,116 | 1,193 | 1,182 | 1,209 | 1,210 | 1,255 | 1,228 | 1,286 | 1,314 | 1,332 | 1,302 | 1,324 | 1,522 | 1,535 | 1,542 | 81.00 | 67.00 | 33.00 |
Current Liabilities | 21.7% | 117 | 96.00 | 103 | 90.00 | 131 | 110 | 126 | 118 | 153 | 107 | 185 | 192 | 205 | 151 | 154 | 135 | 152 | 142 | 37.00 | 23.00 | 29.00 |
Long Term Debt | -100.0% | - | 874 | 874 | 873 | 908 | 911 | 915 | 919 | 922 | 924 | 895 | 910 | 924 | 939 | 953 | 1,167 | 1,182 | 1,196 | - | - | - |
LT Debt, Current | - | - | - | - | - | 18.00 | 15.00 | 13.00 | 11.00 | 9.00 | 7.00 | 78.00 | 63.00 | 63.00 | 63.00 | 55.00 | 47.00 | 39.00 | 31.00 | - | - | - |
LT Debt, Non Current | 0.1% | 875 | 874 | 874 | 873 | 908 | 911 | 915 | 919 | 922 | 924 | 895 | 910 | 924 | 939 | 953 | 1,167 | 1,182 | 1,196 | - | - | - |
Shareholder's Equity | 2.4% | 2,035 | 1,988 | 1,950 | 1,919 | 1,896 | 1,883 | 1,865 | 1,855 | 1,853 | 1,872 | 1,863 | 1,848 | 1,379 | 1,355 | 1,340 | 1,041 | 1,030 | 1,018 | 1,017 | 529 | 477 |
Retained Earnings | 14.7% | 206 | 179 | 165 | 154 | 150 | 150 | 152 | 162 | 176 | 209 | 214 | 218 | 220 | 215 | 213 | 213 | 212 | 212 | 233 | 214 | 172 |
Additional Paid-In Capital | 1.1% | 1,829 | 1,809 | 1,785 | 1,765 | 1,746 | 1,733 | 1,713 | 1,693 | 1,677 | 1,663 | 1,649 | 1,631 | 1,158 | 1,140 | 1,127 | 827 | 819 | 806 | 784 | 316 | 305 |
Accumulated Depreciation | -10.6% | 41.00 | 46.00 | 45.00 | 43.00 | 42.00 | 41.00 | 40.00 | 38.00 | 36.00 | 39.00 | 36.00 | 33.00 | 31.00 | 27.00 | 23.00 | 19.00 | 16.00 | 14.00 | 11.00 | 10.00 | 9.00 |
Shares Outstanding | 0.4% | 86.00 | 86.00 | 86.00 | 85.00 | 85.00 | 84.00 | 84.00 | 84.00 | 84.00 | 84.00 | 83.00 | 82.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | - | 4,300 | - | - | - | 6,100 | - | - | - | 3,900 | - | - | - | 5,700 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 35.0% | 77.00 | 57.00 | 77.00 | 32.00 | 55.00 | 48.00 | 40.00 | 7.00 | 51.00 | 22.00 | 37.00 | 31.00 | 61.00 | 52.00 | 54.00 | 15.00 | 31.00 | 17.00 | 31.00 | 25.00 | 33.00 |
Share Based Compensation | -20.5% | 17.00 | 22.00 | 20.00 | 18.00 | 12.00 | 18.00 | 18.00 | 14.00 | 11.00 | 13.00 | 16.00 | 13.00 | 13.00 | 11.00 | 11.00 | 7.00 | 9.00 | 18.00 | 8.00 | 6.00 | 6.00 |
Cashflow From Investing | 26.9% | -11.27 | -15.42 | -10.25 | -9.13 | -10.28 | -13.53 | -21.12 | -74.20 | -471 | -79.68 | -20.47 | -67.80 | -20.23 | -21.03 | -30.40 | -25.29 | -25.10 | -1,646 | -6.86 | -61.73 | 38.00 |
Cashflow From Financing | 102.9% | 4.00 | 2.00 | -2.15 | -51.03 | -1.15 | -1.09 | -3.39 | 3.00 | -2.97 | -47.22 | 0.00 | 445 | -11.22 | -0.57 | 75.00 | -10.36 | 11.00 | 989 | 461 | 4.00 | 2.00 |
Consolidated statements of operations and comprehensive income (loss) - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Jan. 31, 2024 | Jan. 31, 2023 | Jan. 31, 2022 | |
Revenue | |||
Total revenue | $ 999,587 | $ 861,748 | $ 756,556 |
Cost of revenue | |||
Total cost of revenue | 376,950 | 369,813 | 331,791 |
Gross profit | 622,637 | 491,935 | 424,765 |
Operating expenses | |||
Sales and marketing | 79,273 | 68,849 | 58,605 |
Technology and development | 218,811 | 193,375 | 157,364 |
General and administrative | 103,656 | 97,472 | 85,438 |
Amortization of acquired intangible assets | 92,763 | 94,586 | 82,791 |
Merger integration | 10,435 | 28,596 | 64,805 |
Total operating expenses | 504,938 | 482,878 | 449,003 |
Income (loss) from operations | 117,699 | 9,057 | (24,238) |
Other expense | |||
Interest expense | (55,455) | (48,424) | (36,572) |
Other income (expense), net | 12,796 | 1,271 | (5,931) |
Total other expense | (42,659) | (47,153) | (42,503) |
Income (loss) before income taxes | 75,040 | (38,096) | (66,741) |
Income tax provision (benefit) | 19,328 | (11,953) | (22,452) |
Net income (loss) | 55,712 | (26,143) | (44,289) |
Comprehensive income (loss) | $ 55,712 | $ (26,143) | $ (44,289) |
Net income (loss) per share: | |||
Basic (in usd per share) | $ 0.65 | $ (0.31) | $ (0.53) |
Diluted (in usd per share) | $ 0.64 | $ (0.31) | $ (0.53) |
Weighted-average number of shares used in computing net income (loss) per share: | |||
Basic (in shares) | 85,564 | 84,442 | 83,133 |
Diluted (in shares) | 86,957 | 84,442 | 83,133 |
Service revenue | |||
Revenue | |||
Total revenue | $ 455,690 | $ 452,026 | $ 443,608 |
Cost of revenue | |||
Total cost of revenue | 317,357 | 318,516 | 291,618 |
Custodial revenue | |||
Revenue | |||
Total revenue | 386,594 | 261,282 | 186,119 |
Cost of revenue | |||
Total cost of revenue | 32,502 | 26,101 | 19,492 |
Interchange revenue | |||
Revenue | |||
Total revenue | 157,303 | 148,440 | 126,829 |
Cost of revenue | |||
Total cost of revenue | $ 27,091 | $ 25,196 | $ 20,681 |
Consolidated balance sheets - USD ($) $ in Thousands | Jan. 31, 2024 | Jan. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 403,979 | $ 254,266 |
Accounts receivable, net of allowance for doubtful accounts of $3,947 and $4,989 as of January 31, 2024 and 2023, respectively | 104,893 | 96,835 |
Other current assets | 48,564 | 31,792 |
Total current assets | 557,436 | 382,893 |
Property and equipment, net | 6,013 | 12,862 |
Operating lease right-of-use assets | 48,380 | 56,461 |
Intangible assets, net | 835,948 | 936,359 |
Goodwill | 1,648,145 | 1,648,145 |
Other assets | 67,868 | 52,180 |
Total assets | 3,163,790 | 3,088,900 |
Current liabilities | ||
Accounts payable | 12,041 | 13,899 |
Accrued compensation | 49,608 | 45,835 |
Accrued liabilities | 46,038 | 43,668 |
Current portion of long-term debt | 0 | 17,500 |
Operating lease liabilities | 9,404 | 10,159 |
Total current liabilities | 117,091 | 131,061 |
Long-term liabilities | ||
Long-term debt, net of issuance costs | 874,972 | 907,838 |
Operating lease liabilities, non-current | 48,766 | 58,988 |
Other long-term liabilities | 19,270 | 12,708 |
Deferred tax liability | 68,670 | 82,665 |
Total long-term liabilities | 1,011,678 | 1,062,199 |
Total liabilities | 1,128,769 | 1,193,260 |
Commitments and contingencies (see Note 7) | ||
Stockholders’ equity | ||
Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of January 31, 2024 and 2023 | 0 | 0 |
Common stock, $0.0001 par value, 900,000 shares authorized, 86,127 and 84,758 shares issued and outstanding as of January 31, 2024 and 2023, respectively | 9 | 8 |
Additional paid-in capital | 1,829,384 | 1,745,716 |
Accumulated earnings | 205,628 | 149,916 |
Total stockholders’ equity | 2,035,021 | 1,895,640 |
Total liabilities and stockholders’ equity | $ 3,163,790 | $ 3,088,900 |
 | Mr. Jon Kessler |
---|---|
 | www.healthequity.com |
 | 3170 |